Evidence map›Paper›PMID 31363182›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals.

Henri Margot, Guilaine Boursier, Claire Duflos, Elodie Sanchez, Jeanne Amiel, Jean-Christophe Andrau, Stéphanie Arpin, Elise Brischoux-Boucher, Odile Boute, Lydie Burglen and 51 more

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05937828 ("French National Cohort of Patients With Pediatric-onset of Autoimmune Cytopenia), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05937828 recruitingnot on this map

"French National Cohort of Patients With Pediatric-onset of Autoimmune Cytopenia (OBS'CEREVANCE Cohort)"

Typeobservational_patient_registrySponsorUniversity Hospital, BordeauxRan2010 to 2029Enrolled3,500ConditionsImmune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans SyndromeArmsdata collection
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Short Stature Syndromes: Case Series from India.Journal of pediatric genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

61 authors at 20 institutions in 2 countries.

Henri MargotService de génétique médicale, CHU de Bordeaux, Bordeaux, France.ORCID http://orcid.org/0000-0003-1353-0716
Guilaine BoursierDépartement de génétique médicale, Maladies rares et médecine personnalisée, CHU de Montpellier, Montpellier, France.
Claire DuflosDépartement d'Information Médicale, CHU Montpellier, Montpellier, France.
Elodie SanchezDépartement de génétique médicale, Maladies rares et médecine personnalisée, CHU de Montpellier, Montpellier, France.
Jeanne AmielFédération de Génétique et Institut Imagine, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR1163, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Jean-Christophe AndrauInstitut de Génétique Moléculaire de Montpellier (IGMM), Univ Montpellier, Montpellier, France.
Stéphanie ArpinService de génétique, CHU de Tours, UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
Elise Brischoux-BoucherCentre de Génétique Humaine, Université de Franche-Comté, Besançon, France.ORCID http://orcid.org/0000-0002-4816-1431
Odile BouteCentre de référence maladies rares pour les anomalies du développement Nord-Ouest, Clinique de Génétique médicale, CHU de Lille et EA7364, Université de Lille, Lille, France.
Lydie BurglenCentre de référence des malformations et maladies congénitales du cervelet, département de génétique et embryologie médicale, APHP, GHUEP, Hôpital Trousseau, Paris, France.ORCID http://orcid.org/0000-0002-1119-6809
Charlotte CailleService de génétique médicale, CHU de Brest, Brest, France.
Yline CapriService de génétique médicale, AP-HP Robert-Debré, Paris, France.
Patrick CollignonService de génétique médicale, CHI de Toulon, Toulon, France.
Solène ConradService de génétique médicale, CHU de Nantes, Nantes, France.ORCID http://orcid.org/0000-0003-4996-8357
Valérie Cormier-DaireFédération de Génétique et Institut Imagine, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR1163, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Geoffroy DelplancqCentre de Génétique Humaine, Université de Franche-Comté, Besançon, France.ORCID http://orcid.org/0000-0002-9189-6847
Klaus DieterichService de génétique médicale, CHU de Grenoble, Grenoble, France.
Hélène DollfusService de génétique médicale, CHU de Strasbourg, Strasbourg, France.
Mélanie FradinService de génétique clinique, CHU de Rennes, Univ. Rennes, Institute of Genetics and Development of Rennes (IGDR) UMR6290 CNRS, Rennes, France.
Laurence FaivreService de génétique médicale et centre de référence Anomalies du Développement et Syndromes Malformatifs, CHU de Dijon, Dijon, France.
Helder FernandesService d'onco hématologie pédiatrique, CHU de Bordeaux, Bordeaux, France.
Christine FrancannetService de génétique médicale, CHU de Clemont-Ferrand, Clermont-Ferrand, France.
Vincent GatinoisDépartement de génétique médicale, Maladies rares et médecine personnalisée, CHU de Montpellier, Montpellier, France.
Marion GerardService de génétique médicale, CHU de Caen, Caen, France.
Alice GoldenbergNormandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, F 76000, Normandy Center for Genomic and Personalized Medicine, Rouen, France.
Jamal GhoumidCentre de référence maladies rares pour les anomalies du développement Nord-Ouest, Clinique de Génétique médicale, CHU de Lille et EA7364, Université de Lille, Lille, France.ORCID http://orcid.org/0000-0002-7111-0050
Sarah GrottoService de génétique médicale, AP-HP Robert-Debré, Paris, France.
Anne-Marie GuerrotNormandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, F 76000, Normandy Center for Genomic and Personalized Medicine, Rouen, France.
Agnès GuichetService de génétique médicale, CHU d'Angers, Angers, France.
Bertrand IsidorService de génétique médicale, CHU de Nantes, Nantes, France.
Marie-Line JacquemontService de génétique médicale, CHU de la Reunion, Saint-Pierre, France.
Sophie JuliaService de génétique médicale, CHU de Toulouse, Toulouse, France.
Philippe Khau Van KienService de génétique médicale, CHU de Nîmes, Nîmes, France.
Marine LegendreService de génétique médicale, CHU de Bordeaux, Bordeaux, France.
K H Le Quan SangInstitut Imagine, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Bruno LeheupService de génétique médicale, CHU de Nancy, Nancy, France.
Stanislas LyonnetFédération de Génétique et Institut Imagine, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR1163, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Virginie MagryService de génétique médicale, CHU de Clemont-Ferrand, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0002-5382-480X
Sylvie ManouvrierCentre de référence maladies rares pour les anomalies du développement Nord-Ouest, Clinique de Génétique médicale, CHU de Lille et EA7364, Université de Lille, Lille, France.
Dominique MartinService de génétique médicale, CH du Mans, Le Mans, France.
Godelieve MorelService de génétique médicale, CHU de Nice, Nice, France.
Arnold MunnichFédération de Génétique et Institut Imagine, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR1163, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Sophie NaudionService de génétique médicale, CHU de Bordeaux, Bordeaux, France.
Sylvie OdentService de génétique clinique, CHU de Rennes, Univ. Rennes, Institute of Genetics and Development of Rennes (IGDR) UMR6290 CNRS, Rennes, France.
Laurence PerrinService de génétique médicale, AP-HP Robert-Debré, Paris, France.
Florence PetitCentre de référence maladies rares pour les anomalies du développement Nord-Ouest, Clinique de Génétique médicale, CHU de Lille et EA7364, Université de Lille, Lille, France.ORCID http://orcid.org/0000-0002-1368-1023
Nicole PhilipService de génétique médicale, CHU de Marseille, Marseille, France.
Marlène RioFédération de Génétique et Institut Imagine, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR1163, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Julie RobbeService de génétique médicale, CHU de Marseille, Marseille, France.ORCID http://orcid.org/0000-0003-2938-7088
Massimiliano RossiService de génétique médicale, CHU de Lyon, Lyon, France.
Elisabeth SarrazinCentre de Référence Anomalies du développement et Syndromes malformatifs du Sud-Ouest Occitanie Réunion, Saint-Pierre, France.
Annick ToutainService de génétique, CHU de Tours, UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.ORCID http://orcid.org/0000-0002-5999-5300
Julien Van GilsService de génétique médicale, CHU de Bordeaux, Bordeaux, France.
Gabriella VeraNormandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, F 76000, Normandy Center for Genomic and Personalized Medicine, Rouen, France.ORCID http://orcid.org/0000-0001-8352-5563
Alain VerloesService de génétique médicale, AP-HP Robert-Debré, Paris, France.
Sacha WeberService de génétique médicale, CHU de Caen, Caen, France.ORCID http://orcid.org/0000-0001-9363-5141
Sandra WhalenService de génétique médicale, AP-HP Pitié Salpétrière, Paris, France.
Damien SanlavilleService de génétique médicale, CHU de Lyon, Lyon, France.
Didier LacombeService de génétique médicale, CHU de Bordeaux, Bordeaux, France.
Nathalie AladjidiService d'onco hématologie pédiatrique, CHU de Bordeaux, Bordeaux, France.
David GenevièveDépartement de génétique médicale, Maladies rares et médecine personnalisée, CHU de Montpellier, Montpellier, France. d-genevieve@chu-montpellier.fr.
Inserm · FRDélégation Paris 5 · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Lille · FRGénétique Médicale & Génomique Fonctionelle · FRUniversité de Bordeaux · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Nantes · FRCentre National de la Recherche Scientifique · FRSorbonne Université · FRUniversité de franche-comté · FRUniversité de Tours · FRCentre Hospitalier du Mans · FRCentre Hospitalier Régional Universitaire de Brest · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de La Réunion · FRCentre Hospitalier Universitaire de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeKabuki syndrome (KS) (OMIM 147920 and 300867) is a rare genetic disorder characterized by specific facial features, intellectual disability, and various malformations. Immunopathological manifestations seem prevalent and increase the morbimortality. To assess the frequency and severity of the manifestations, we measured the prevalence of immunopathological manifestations as well as genotype-phenotype correlations in KS individuals from a registry.

methodsData were for 177 KS individuals with KDM6A or KMT2D pathogenic variants. Questionnaires to clinicians were used to assess the presence of immunodeficiency and autoimmune diseases both on a clinical and biological basis.

resultsOverall, 44.1% (78/177) and 58.2% (46/79) of KS individuals exhibited infection susceptibility and hypogammaglobulinemia, respectively; 13.6% (24/177) had autoimmune disease (AID; 25.6% [11/43] in adults), 5.6% (10/177) with ≥2 AID manifestations. The most frequent AID manifestations were immune thrombocytopenic purpura (7.3% [13/177]) and autoimmune hemolytic anemia (4.0% [7/177]). Among nonhematological manifestations, vitiligo was frequent. Immune thrombocytopenic purpura was frequent with missense versus other types of variants (p = 0.027).

conclusionThe high prevalence of immunopathological manifestations in KS demonstrates the importance of systematic screening and efficient preventive management of these treatable and sometimes life-threatening conditions.

Indexed as

Abnormalities, MultipleAdolescentAdultAgedAutoimmune DiseasesChildChild, PreschoolDNA-Binding ProteinsFaceFemaleGenetic Association StudiesHematologic DiseasesHistone DemethylasesHumansInfantInfant, NewbornDNA-Binding ProteinsHistone DemethylasesKDM6A protein, humanKMT2D protein, humanNeoplasm ProteinsimmunityKabuki syndromeKDM6AKMT2D

Identifiers

PMID31363182
OpenAlexW2966178841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.